Rosacea was consistently diagnosed correctly from images, while atopic dermatitis and squamous cell carcinoma proved more ...

Pharmacokinetic (PK) model generated based on the single ascending dose (SAD) data and the first multiple ascending dose (MAD ...

Bubble baths might be soothing soaks, but bubble showers could be the next thing in keeping the skin clean. An Osaka Metropolitan University-led medical research team found that ultrafine ...

A newly developed Naples Pediatric Food Allergy grading scale, incorporating clinical history and examination, shows promise in streamlining the diagnosis of food allergies in children, potentially ...

The model used to summarize this release may ... in patients with moderate to severe atopic dermatitis (AD). The Company expects to report data from the BroADen trial in the fourth quarter of ...

Patients with hidradenitis suppurativa and melanoma had a greater risk of completed suicide, while no association was seen for other skin diseases.

Raelle Kennedy spent years managing the skin manifestations of her eczema. Topical steroid withdrawal urged her to get at the ...

ZTS reports better-than-expected first-quarter results as earnings and revenues surpass estimates. Management raises 2025 ...

Starting in 2025, the Eylea franchise as a whole began to decline due to competitive pressure from long-acting Vabysmo, which competes with Eylea HD, and Pabvlu, a biosimilar version of the original ...

As part of its ongoing 'Your Health, Our Priority' campaign, Hamad Medical Corporation (HMC) highlighted the exceptional ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.